Begin main content

Natalizumab

Last Updated: October 26, 2006
Result type: Reports
Project Number: S0082
Product Line: Common Drug Review

Generic Name: Natalizumab

Brand Name: Tysabri

Manufacturer: Biogen Idec Canada Inc.

Indications: Multiple Sclerosis, relapsing-remitting

Submission Type: New

Project Status: Complete

Date Recommendation Issued: April 26, 2007

Recommendation Type: Do not list